Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIPHER: Carnosine in Peripheral Arterial Disease
NCT06480760Phase 2Recruiting
- Start
- May 2025
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms). Primary endpoint: Six-Minute Walk Test Distance at 6 months. Started May 2025; status: recruiting.
Beyond the preview
Go deeper on NCT06480760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06480760.